These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19269170)

  • 1. 3-Hydroxy-4-oxo-4H-pyrido[1,2-a]pyrimidine-2-carboxylates--a new class of HIV-1 integrase inhibitors.
    Donghi M; Kinzel OD; Summa V
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1930-4. PubMed ID: 19269170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroxy-pyrimidine and N-methylpyrimidone HIV-integrase inhibitors: improving cell based activity by the quaternarization of a chiral center.
    Nizi E; Orsale MV; Crescenzi B; Pescatore G; Muraglia E; Alfieri A; Gardelli C; Spieser SA; Summa V
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4617-21. PubMed ID: 19616948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of C2-carbon-linked heterocyclic-5-hydroxy-6-oxo-dihydropyrimidine-4-carboxamides as HIV-1 integrase inhibitors.
    Naidu BN; Sorenson ME; Patel M; Ueda Y; Banville J; Beaulieu F; Bollini S; Dicker IB; Higley H; Lin Z; Pajor L; Parker DD; Terry BJ; Zheng M; Martel A; Meanwell NA; Krystal M; Walker MA
    Bioorg Med Chem Lett; 2015 Feb; 25(3):717-20. PubMed ID: 25529736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 5-(1-H or 1-alkyl-5-oxopyrrolidin-3-yl)-8-hydroxy-[1,6]-naphthyridine-7-carboxamide inhibitors of HIV-1 integrase.
    Melamed JY; Egbertson MS; Varga S; Vacca JP; Moyer G; Gabryelski L; Felock PJ; Stillmock KA; Witmer MV; Schleif W; Hazuda DJ; Leonard Y; Jin L; Ellis JD; Young SD
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5307-10. PubMed ID: 18774711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-(4-Fluorobenzyl)-3-hydroxy-9,9-dimethyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrazino[1,2-a]pyrimidine-2-carboxamides a novel class of potent HIV-1 integrase inhibitors.
    Petrocchi A; Jones P; Rowley M; Fiore F; Summa V
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4245-9. PubMed ID: 19523819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triketoacid inhibitors of HIV-integrase: a new chemotype useful for probing the integrase pharmacophore.
    Walker MA; Johnson T; Ma Z; Banville J; Remillard R; Kim O; Zhang Y; Staab A; Wong H; Torri A; Samanta H; Lin Z; Deminie C; Terry B; Krystal M; Meanwell N
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2920-4. PubMed ID: 16546383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroxypyrimidine-4-carboxamides as novel potent and selective HIV integrase inhibitors.
    Pace P; Di Francesco ME; Gardelli C; Harper S; Muraglia E; Nizi E; Orvieto F; Petrocchi A; Poma M; Rowley M; Scarpelli R; Laufer R; Gonzalez Paz O; Monteagudo E; Bonelli F; Hazuda D; Stillmock KA; Summa V
    J Med Chem; 2007 May; 50(9):2225-39. PubMed ID: 17428043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antiviral activity of 7-benzyl-4-hydroxy-1,5-naphthyridin-2(1H)-one HIV integrase inhibitors.
    Boros EE; Edwards CE; Foster SA; Fuji M; Fujiwara T; Garvey EP; Golden PL; Hazen RJ; Jeffrey JL; Johns BA; Kawasuji T; Kiyama R; Koble CS; Kurose N; Miller WH; Mote AL; Murai H; Sato A; Thompson JB; Woodward MC; Yoshinaga T
    J Med Chem; 2009 May; 52(9):2754-61. PubMed ID: 19374386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4,5-dihydroxypyrimidine carboxamides and N-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic profiles in preclinical species.
    Summa V; Petrocchi A; Matassa VG; Gardelli C; Muraglia E; Rowley M; Paz OG; Laufer R; Monteagudo E; Pace P
    J Med Chem; 2006 Nov; 49(23):6646-9. PubMed ID: 17154493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of substituted 4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxamides, novel HIV-1 integrase inhibitors.
    Langford HM; Williams PD; Homnick CF; Vacca JP; Felock PJ; Stillmock KA; Witmer MV; Hazuda DJ; Gabryelski LJ; Schleif WA
    Bioorg Med Chem Lett; 2008 Jan; 18(2):721-5. PubMed ID: 18078751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of polyhydroxylated aromatics having amidation of piperazine nitrogen as HIV-1 integrase inhibitor.
    Yang L; Xu X; Huang Y; Zhang B; Zeng C; He H; Wang C; Hu L
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5469-71. PubMed ID: 20709544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
    Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and discovery of 5-hydroxy-6-oxo-1,6-dihydropyrimidine-4-carboxamide inhibitors of HIV-1 integrase.
    Zhang D; Debnath B; Yu S; Sanchez TW; Christ F; Liu Y; Debyser Z; Neamati N; Zhao G
    Bioorg Med Chem; 2014 Oct; 22(19):5446-53. PubMed ID: 25150089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydrazide-containing inhibitors of HIV-1 integrase.
    Zhao H; Neamati N; Sunder S; Hong H; Wang S; Milne GW; Pommier Y; Burke TR
    J Med Chem; 1997 Mar; 40(6):937-41. PubMed ID: 9083482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural modifications of 5,6-dihydroxypyrimidines with anti-HIV activity.
    Guo DL; Zhang XJ; Wang RR; Zhou Y; Li Z; Xu JY; Chen KX; Zheng YT; Liu H
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7114-8. PubMed ID: 23099098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series.
    De Luca L; Barreca ML; Ferro S; Iraci N; Michiels M; Christ F; Debyser Z; Witvrouw M; Chimirri A
    Bioorg Med Chem Lett; 2008 May; 18(9):2891-5. PubMed ID: 18417342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors.
    Kawasuji T; Fuji M; Yoshinaga T; Sato A; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8420-9. PubMed ID: 17005407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors.
    Plewe MB; Butler SL; Dress KR; Hu Q; Johnson TW; Kuehler JE; Kuki A; Lam H; Liu W; Nowlin D; Peng Q; Rahavendran SV; Tanis SP; Tran KT; Wang H; Yang A; Zhang J
    J Med Chem; 2009 Nov; 52(22):7211-9. PubMed ID: 19873974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and anti-integrase activity of catechol-DKA hybrids.
    Maurin C; Bailly F; Mbemba G; Mouscadet JF; Cotelle P
    Bioorg Med Chem; 2006 May; 14(9):2978-84. PubMed ID: 16412645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of novel β-diketo derivatives as HIV-1 integrase inhibitors.
    Hu L; Zhang S; He X; Luo Z; Wang X; Liu W; Qin X
    Bioorg Med Chem; 2012 Jan; 20(1):177-82. PubMed ID: 22154762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.